Company
Curevo
We're dedicated to developing non-mRNA vaccines for unmet medical needs
Also known as Curevo Inc
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Curevo Inc
Claim, correct or request removal
Record updated 29 September 2026
About
Curevo Vaccine is a clinical-stage biotech company dedicated to developing next-generation non-mRNA vaccines. We focus on one need at a time, allowing us to bring effective and better-tolerated vaccines to market quickly and efficiently.
Funding snapshot
- Total raised
- $110MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $42.4M2025-03-06
Funding rounds
- Round, 2025
- $42.4M2025-03-06, SEC form D sold, 11 investors
- Round, 2022
- $22M2022-11-10, SEC form D sold, 7 investors
- Round, 2021
- $45.6M2021-12-29, SEC form D sold, 7 investors
Products
- Other
- amezosvatein (CRV-101)
Loading relationship preview